IPO Issue Details
Issue Price / Price Band₹145 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,000 Shares per Lot
Total Issue Size47,93,000 shares (aggregating up to ₹69.50 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenFri, 22 Aug 2025
Subscription CloseTue, 26 Aug 2025
Anchor AllotmentThu, 21 Aug 2025
Basis of AllotmentThu, 28 Aug 2025
Initiation of RefundsFri, 29 Aug 2025
Credit of Shares to DematFri, 29 Aug 2025
Listing DateMon, 01 Sep 2025
UPI Mandate Deadline2025-08-26
Application & Investment Details
Retail — Min (2 Lots)₹2,90,000 — 2000 shares
Retail — Max (13 Lots)₹1,885,000 (13 Lots)
HNI — Min (3 Lots)₹4,35,000 — 3000 shares
EPS (Pre-IPO)₹12.35
EPS (Post-IPO)₹9.08
P/E Ratio (Pre-IPO)11.74x
P/E Ratio (Post-IPO)15.98x
Net Offer to Public45,23,000 shares (aggregating up to ₹65.58 Cr)
Reserved for Market Maker2,70,000 shares (aggregating up to ₹3.92 Cr)
Pre-IPO Promoter Holding1,32,93,618 shares
Post-IPO Promoter Holding1,80,86,618 shares
About Anondita Medicare Ltd.
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.” The company produces 562 million condoms annually.The company has a manufacturing facility situated in Noida, Uttar Pradesh.Anondita Medicare exports its products to several international markets, including Southeast Asia, Africa, and the Middle East.The company collaborates with global health organizations, NGOs, and governments to support family planning and public health initiatives.Anondita Medicare has a robust distribution network that ensures the timely delivery of its products to various markets.The company collaborates with wholesalers, retailers, and e-commerce platforms to make its products widely accessible. It also has strong ties with government health programs and institutions, playing a key role in supplying essential medical products for public health initiatives.As on July 31, 2025, the Company had 280 employees.Competitive Strength:Experienced and significant condom manufacturer in India.Well-recognized in North IndiaOffers a diverse range of products.
Objects of the Issue
Anondita Medicare Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Funding capital expenditure requirements for the purchase of equipment/machineries
6.00
2
2 Funding the Working Capital requirement
35.00
3
3 Unidentified Acquisition and General Corporate Purposes
20.16
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,32,93,618 shares
Post-IPO Promoter Holding
1,80,86,618 shares